Budesonide Microemulsions for Enhancing Solubility and Dissolution Rate |
Piao, Hong-Mei
(College of Pharmacy and Research Institute for Pharmaceutical Sciences, Seoul National University)
Cho, Hyun-Jong (College of Pharmacy and Research Institute for Pharmaceutical Sciences, Seoul National University) Oh, Eui-Chaul (STH Pharm Inc) Chung, Suk-Jae (College of Pharmacy and Research Institute for Pharmaceutical Sciences, Seoul National University) Shim, Chang-Koo (College of Pharmacy and Research Institute for Pharmaceutical Sciences, Seoul National University) Kim, Dae-Duk (College of Pharmacy and Research Institute for Pharmaceutical Sciences, Seoul National University) |
1 | S. Divya, S. Elizabeth and K. Deepak, Allergic Rhinitis, Clin. Pediatr., 46, 401-407 (2007). DOI ScienceOn |
2 | H.K. John, Allergic rhinitis - Current pharmacotherapy, Otolaryngol. Clin. N. Am., 41, 347-358 (2008). DOI ScienceOn |
3 | C. LaForce and N.C. Raleigh, Use of nasal steroids in managing allergic rhinitis, J. Allergy Clin. Immunol., 103, S388-394 (1999). DOI ScienceOn |
4 | H. Derendorf and E.O. Meltzer, Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications, Allergy, 63, 1292-1300 (2008). DOI ScienceOn |
5 | K. Deventer, P. Mikulcikova, H. Van Hoecke, P. Van Eenoo and F.T. Delbeke, Detection of budesonide in human urine after inhalation by liquid chromatography–mass spectrometry, J. Pharm. Biomed. Anal., 40, 423-428 (2006). DOI ScienceOn |
6 | S. Edsbacker, P. Andersson, C. Lindberg, A. Ryrfeldt and A. Thalen, Metabolic acetal splitting of budesonide. A novel inactivation pathway for topical glucocorticoids, Drug Metab. Dispos., 15, 412-417 (1987). |
7 | J.S. Stanley and C. Denver, Pharmacokinetics of intranasal corticosteroids, J. Allergy Clin. Immunol., 108, S26-31 (2001). DOI ScienceOn |
8 | M.A. Lopez-Quintela, C. Tojo, M.C. Blanco, L. Garcia Rio and J.R. Leis, Microemulsion dynamics and reactions in microemulsions, Curr. Opin. Colloid Interface Sci., 9, 264-278 (2004). DOI ScienceOn |
9 | A. Morgan, G. Lennart and W. Per, Nasal treatment with a microemulsion reduces allergenchallenge-induced symptoms and signs of allergic rhinitis, Acta Otolaryngol., 128, 666-669 (2008). DOI ScienceOn |
10 | Z. Hu, R. Tawa, T. Konishi, N. Shibata and K. Takada, A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin, Life Sci., 69, 2899–2910 (2001). |
11 | N. Chidambaram and D.J. Burgess, A novel in vitro release method for submicron sized dispersed systems, AAPS Pharm. Sci., 1, E11 (1998). DOI |
12 | L. Djekic and M. Primorac, The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides, Int. J. Pharm., 352, 231-239 (2008). DOI ScienceOn |
13 | M.I. Ugwoke, R.U. Agu, N. Verbeke and R. Kinget, Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives, Adv. Drug Deliv. Rev., 57, 1640-1665 (2005). DOI ScienceOn |
14 | K. Danjo, F. Higuchi and A. Otsuka, Release of lidocaine from polymer film dosage forms, Chem. Pharm. Bull., 43, 1759-1763 (1995). DOI ScienceOn |
15 | T. Furubayashi, D. Inoue, A. Kamaguchi, Y. Higashi and T. Sakane, Influence of formulation viscosity on drug absorption following nasal application in rats, Drug Metab. Pharmacokinet., 22, 206-211 (2007). DOI ScienceOn |
16 | A.H. Anwar, Intranasal drug delivery, Adv. Drug Deliv. Rev., 129, 39-49 (1998). |
17 | T. Selcan, O. Erte and O. Yekta, Nasal route and drug delivery systems, Pharm. World Sci., 26, 137-142 (2004). DOI ScienceOn |